A substantial advance in our understanding on the estrogen signaling occurred in the last decade. Estrogens interact with two receptors, ESR1 and ESR2, also known as ERα and ERβ, respectively. ESR1 and ESR2 belong to the nuclear receptor family of transcription factors. 24 male mice divided into four groups as following : negative control, low dose group, intermediate dose group and high dose group, the groups of treatment were injected with estrogen at different doses while the negative control group were injected with normal saline (by method of intramuscular injection for all groups) and after 6 weeks all animals had been killed and the prostate was picked up and sectioned to reveal the histopathological changes. the study found that the injection of exogenous estrogen result in marked hyperplasia of the prostatic tissue and the hyperplasia increased significantly with elevation of the estrogen dose. In conclusion injection of exogenous estrogen lead to prostate hyperplasia through its action on the estrogen receptors which present in both stromal and epithelial component of the prostate.
INTRODUCTION
It is known that there are both significant similarities in the gross and microscopic anatomy of the mouse and the human prostates, and these need to be considered when evaluating murine models of human prostatic disease. Both mouse and human have similar epithelial cell types present in their prostates (secretory, basal and neuroendocrine), which presumably carry out the same physiological functions, but the ratio varies between species. Both species have columnar secretory epithelial cells which secrete prostatic proteins and fluids from their apical surfaces into a lumen. Humans have a continuous layer of basal cells between the secretary cells and the basement membrane, whereas mice have fewer basal cells and a discontinuous layer around the glands (1). Neuroendocrine cells are scattered and rare in human prostate, and even more rare in the mouse (2). The prostates of both species are composed of glands and ducts, but there are significant differences in the stroma. The human prostate has a robust fibro muscular stroma. The mouse prostate has a very modest stromal component. Both species have prostates and accessory glands that develop from Wolffian ducts and urogenital sinuses and both are androgen-sensitive (3). There are many embryological, anatomical and histological similarities between mouse and human prostate tissues (4).
The etiology of benign prostate hyperplasia (BPH) is still poorly understood, it is thought to be related to the combination of aging and endocrine dysregulation (5) . It is well documented that androgens are the primary factor for prostate disease (6) , but the mechanism is still unclear (7) . While the prostate is considered the prototype androgen-dependent gland, there is rising evidence that estrogen is necessary to maintain the natural function of prostate (8, 9) . In addition, estrogens also play an important role in growth and differentiation of prostate gland (10) .
Prostate tissue is also most probably a target for direct regulation by estrogens.
Prostate contains estrogen receptor (ERα) and (ERβ), which are localized characteristically in stroma and epithelium, respectively (11) . The physiological function of these receptors is not known but there is evidence of the role of estrogens in prostatic hyperplasia and carcinogenesis. Developing prostate seems particularly sensitive to increased level of endogenous and/or exogenous estrogens (12). So this study had been accomplished in order to confirm that elevation of the serum level of estrogen cause benign prostate hyperplasia.
MATERIALS AND METHODS
Twenty four male laboratory mice were divided into four groups each group consist of six animals, the animals of each group were housed together in same conditions with free access of food and water. The groups of animals include : negative control group in which the animals injected with normal saline, low dose group, animals in this group were injected with (5 mg/ kg), intermediate dose group, in which the animals injected with (10 mg/kg) which is the therapeutic dose of the estrogen, high dose group, animals were injected with (20 mg/kg) by intramuscular injection for all groups.
animals of all groups injected with estrogen daily for six weeks and the animals observed clinically all period of treatment, then the animals had been killed and the prostate collected and sectioned in the pathology laboratory and stained with routine (H&E) stain to reveal the histopathological changes.
RESULTS
The behaviors of the animals in the negative control group appear normal as well as the histology of the prostate appear with normal limits as shown in the figures (1,2).
The daily clinical observation of the animals of the low dose groups revealed that these animals showed some difficulties in the urination appear in the fifth week of administration which indicated by interrupted urination and this sign continue till the end of experiment. The clinical observation of the animals in the group of high dose revealed the difficulties in the urination appeared in the third week, then urine retention appear in the fourth week, the urinary bladder was palpable because it was over distended with urine as shown in the figure (10) and it was very difficult to assist the animal for urination even by the massage of the bladder and urethra.
Histopathological examination reveal that the prostate tissue appear with marked hyperplastic epithelium with papillary projections to the lumen of the gland which is nearly completely close the lumen and stromal thickening as shown in the figures (8, 9) . 
DISCUSSION
The present study tends to evaluate the effect of elevated estrogen levels in the blood on the prostatic tissue since the prostate have a widely distributed Estrogen receptors in both epithelium and stroma (13) , and the causes of benign prostate hyperplasia still controversial matter. so the present study tend to confirm that the elevation of the estrogen level is one of the considerable causes for this common pathological conditions in the human particularly in the middle age and elderly persons through working on experimental animals.
Estrogens, acting via estrogen receptors (ER) α and β, exert direct and indirect actions on prostate growth and differentiation (14) . The presence of estrogen receptors in prostate suggests that estrogens may act directly on multiple sites in prostate.
Interestingly, the two ER subtypes have very different expression patterns. In human and rodent prostate, ERβ is the predominant ER subtype, expressed in the majority of the epithelial cells, as well as in some stromal cells (15) . ERα is expressed in a more 
